Fairtility

About Fairtility

Fairtility is a startup that leverages artificial intelligence (AI) to enhance the process and outcomes of in-vitro fertilization (IVF). The company's primary offering is CHLOE™, an AI-based decision support system that provides IVF professionals with comprehensive insights into clinical and laboratory parameters. This system is designed to facilitate more informed discussions between clinicians and patients, thereby reducing the emotional, physical, and financial strain often associated with IVF procedures.

The company operates in the healthcare technology market, specifically targeting IVF clinics and professionals. Its business model revolves around providing a subscription-based service to these clinics, offering them access to CHLOE™ and its data-driven insights. This system is trained using millions of data points, including patient and embryo data, and has been clinically validated on over 50,000 embryos from various clinics worldwide.

Fairtility's primary revenue stream comes from the subscription fees paid by IVF clinics for access to CHLOE™. The system's ability to predict embryonic development stages and implantation with high accuracy rates (96% for blastocyst prediction and 73% for implantation prediction) offers significant value to these clinics, potentially improving their success rates and patient satisfaction.

In summary, Fairtility is a healthcare tech startup that uses AI to improve IVF outcomes. Its innovative system, CHLOE™, provides IVF professionals with data-driven insights, aiming to reduce the number of IVF cycles and the associated burdens on prospective parents.